Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2007-02-20
2007-02-20
Page, Thurman K. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C564S248000, C562S504000
Reexamination Certificate
active
10309754
ABSTRACT:
The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of derivatives of cyclopentenone for the inhibition and/or prevention of cancer of the colon, pancreas, larynx, ovary, duodenum, kidney, oral cavity, prostate, lung, endothelial cells and leukemias.
REFERENCES:
Challener et al., Journal of the American Chemical Society (1993), 115(4), 1359-76.
Melchiorre et al. European Journal of Medicinal Chemistry (1975), 10(6), 623-7, Chemical Abstract online citation.
Shoppee et al. Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999) (1972), (18), 2271-6 Chemical Abstracts online citation.
Chemical Abstracts online citation [retrieved Mar. 30, 2006] from STN, Columbus, OH, USA, Abstract No. 1951:11128.
Burman Anand C.
Chandrasekhar Srivari
Desiraju Gautam R.
Gurjar Mukund K.
Jaggi Manu
Dabur Research Foundation
Ladas & Parry
Page Thurman K.
Puttlitz Karl
LandOfFree
Cyclopentenone derivatives for cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentenone derivatives for cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentenone derivatives for cancer therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3867096